{
    "organizations": [],
    "uuid": "ac6b362866e98db09d42426be4ee30f72e9428d2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dermapharm-holding-fy-adjusted-ebi/brief-dermapharm-holding-fy-adjusted-ebitda-up-9-7-pct-at-eur-113-million-idUSFWN1RL02L",
    "ord_in_thread": 0,
    "title": "BRIEF-Dermapharm Holding FY Adjusted EBITDA Up 9.7 Pct At EUR 113 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 9 (Reuters) - Dermapharm Holding SE:\n* REVENUE IN 2017 UP 4.9% FROM LAST YEAR TO EUR 467 MILLION\n* FY ADJUSTED EBITDA UP 9.7% FROM LAST YEAR TO EUR 113 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-09T13:40:00.000+03:00",
    "crawled": "2018-04-10T12:41:54.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "dermapharm",
        "holding",
        "se",
        "revenue",
        "last",
        "year",
        "eur",
        "million",
        "fy",
        "adjusted",
        "ebitda",
        "last",
        "year",
        "eur",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}